The Centers for Medicare & Medicaid Services said it has made "significant" changes in Medicare's approach to paying for drugs administered in the physician's office that will allow increased coverage in 2005 for both the drugs and their administration.
The Centers for Medicare & Medicaid Services said it has made "significant" changes in Medicare's approach to paying for drugs administered in the physician's office that will allow increased coverage in 2005 for both the drugs and their administration. However, the reimbursement rates for a number of drugs commonly used to treat prostate and bladder cancer appear to be dropping significantly.
According to a CMS press release discussing the final rule for physician payment for 2005, the higher payments are based on data from the American Society for Clinical Oncology and include payment for staff time to prepare pharmaceuticals and physician work for supervising of their preparation. Information about reimbursement for specific urology drugs was not available as this issue of Urology Times E-news was being prepared.
The final rule will be published in Nov. 15, 2004 Federal Register. Look for details on the new fee schedule's impact on urologists in the December issue of Urology Times.
Medicare’s G2211 and thoughts on how to best use it in urology
May 1st 2024"We felt that it was important to again address this topic because we have received numerous questions regarding the correct use of this code and we have had some experience using the code now that it is active and been able to observe some of the initial payment processing by the payer," write Jonathan Rubenstein, MD, and Mark Painter.
Experts develop guide on online tools to reduce costs of urologic drugs
April 22nd 2024"At a time when patients are increasingly concerned about prescription drugs, this information will provide a useful starting point for making essential medications as affordable as possible," says Ruchika Talwar, MD.